Company Encyclopedia
View More
name
LifeStance Health
LFST.US
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers.
384.02 B
LFST.USMarket value -Rank by Market Cap -/-

Financial Score

22/11/2025 Update
C
Health Care ServicesIndustry
Industry Ranking28/80
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-0.62%D
    • Profit Margin-0.67%D
    • Gross Margin32.04%C
  • Growth ScoreB
    • Revenue YoY13.39%B
    • Net Profit YoY90.43%A
    • Total Assets YoY1.95%C
    • Net Assets YoY3.87%C
  • Cash ScoreD
    • Cash Flow Margin-15000.22%E
    • OCF YoY13.39%B
  • Operating ScoreB
    • Turnover0.64B
  • Debt ScoreB
    • Gearing Ratio30.54%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    VP Miller Files To Sell 57,240 Of Lifestance Health Group Inc [LFST]

    Lisa K. Miller, VP of Lifestance Health Group Inc, filed a Form 144 to sell 57,240 shares of the company on November 21, 2025, through Fidelity Brokerage Services. This filing with the SEC allows the sale of restricted securities within 90 days.

    Reuters·
    US
    LFST
    +4.21%
    Reuters·
    US
    LFST
    +4.21%

    VP Miller Surrenders 10,623 Of Lifestance Health Group Inc [LFST]

    VP Lisa K. Miller of Lifestance Health Group Inc. surrendered 10,623 shares back to the company to cover option exercise costs and/or tax liabilities. The transaction was filed with the SEC on November 13, 2025, with the shares valued at $68,306. Miller's ending holdings are 318,532 shares directly.

    Reuters·
    US
    LFST
    +4.21%
    Reuters·
    US
    LFST
    +4.21%

    Officer Varanakis Acquires 113,423 Of Lifestance Health Group Inc [LFST]-Amended

    Officer Varanakis of Lifestance Health Group Inc [LFST] reported acquiring 113,423 shares in a Form 4/A filed on November 12, 2025. The report details transactions from March 6 to March 7, 2025, including the exercise of 135,934 shares at $0.00 and the surrender of 22,511 shares at $7.67, totaling $172,729. Varanakis now holds 376,430 shares directly after these transactions.

    Reuters·
    US
    LFST
    +4.21%
    Reuters·
    US
    LFST
    +4.21%

    LifeStance Health Group Inc reports results for the quarter ended September 30 - Earnings Summary

    LifeStance Health Group Inc reported breakeven earnings per share for the quarter ended September 30, surpassing last year's EPS of -2 cents and analysts' expectations of a loss. Revenue increased by 16.3% to $363.81 million, exceeding the expected $355.60 million. The company achieved a net income of $1.08 million. Analyst ratings are predominantly "buy," with a median 12-month price target of $8.75, indicating a potential upside of 28.6% from the last closing price of $6.25.

    Reuters·
    US
    LFST
    +4.21%
    Reuters·
    US
    LFST
    +4.21%

    Positive Outlook for LifeStance Health Group: Overcoming Challenges and Driving Growth with Strategic Initiatives

    Morgan Stanley analyst Craig Hettenbach has maintained a Buy rating on LifeStance Health Group with a price target of $10.00, citing a positive outlook due to improved clinician productivity and increased patient visits. The company is overcoming challenges like payor rate reductions and is implementing strategic initiatives, including a cash incentive program and AI-assisted scheduling, to enhance efficiency. Canaccord Genuity also supports this view with a Buy rating and a price target of $8.00, highlighting LifeStance's strong growth potential and healthy balance sheet for future acquisitions.

    Tip Ranks·
    US
    LFST
    +4.21%
    Tip Ranks·
    US
    LFST
    +4.21%